Scientists have identified chemicals that could protect vital organs from long-term damage following a heart attack or stroke, according to new research in mice, part-funded by the British Heart Foundation (BHF) and Medical Research Council (MRC). The researchers now hope the chemicals will provide a starting point for developing new injectable drugs that could be […]

  Following years of research by Dr Joseph Cheriyan, Prof Ian Wilkinson, Dr James Rudd, and many others, GlaxoSmithKline (GSK) has announced a new Phase III clinical trial – LATITUDE-TIMI 60 – to test a new losmapimod drug in more than 25,000 patients with acute coronary syndrome.  For more information please click on the links below: […]

Close academic and industry collaborations between GSK and NIHR Cambridge BRC drive forward new clinical trials for heart disease. A new Phase III clinical trial in patients with heart disease has just commenced following years of seminal research work at the NIHR Cambridge Biomedical Research Centre (BRC). The LATITUDE-TIMI 60 trial funded by GlaxoSmithKline (GSK), […]

 A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge. The incidence of cardiovascular disease varies worldwide, but is notably reduced in southern Europe, where a ‘Mediterranean diet’ consisting of a larger consumption of fruit, […]